Industry & Business

Diaceutics Raises €4.3 Million to Support Global Expansion

 Breaking News
  • Grand Canal Innovation District Planned For Dublin A far-reaching plan for the creation of the Grand Canal Innovation District in Dublin has been launched. The proposal from Trinity College Dublin is modelled on innovation districts in cities such as Boston, Toronto, Rotterdam and Barcelona. It will significantly strengthen Ireland’s competitive advantage when developing new indigenous companies or competing for foreign direct investment. [...]...
  • Heiton Buckley Unveils Newly Refurbished Mayo Branch Heiton Buckley, Ireland’s leading supplier of doors, floors, bathrooms, garden, plumbing and heating products, has officially unveiled its newly refurbished branch in Castlebar, County Mayo . GAA star, Andy Moran, CEO of Grafton Merchanting ROI, Patrick Atkinson, Heiton Buckley Castlebar Branch Manager, Mick Kane, and longtime customer Mick Duane officially cut the ribbon and kicked [...]...
  • Export Sales by Enterprise Ireland Client Companies Hit New Record Enterprise Ireland, the state agency responsible for helping Irish companies export to international markets, has announced that its clients recorded export sales of €22.71 billion in 2017, representing a 7 per cent increase on 2016. This is the highest level of export sales recorded in the history of the agency and the eighth-consecutive year of [...]...
  • BAM Wins €25 Million Contract to Build New Cheese Factory in Cork TINE Ireland, a subsidiary of the Norwegian dairy co-operative TINE, has awarded the construction of a new Jarlsberg® cheese production facility and administration building at Mogeely, County Cork, to BAM Ireland. The contract value is more than €25 million. TINE is Norway’s largest producer, distributor and exporter of dairy products with 11,400 members (owners) and [...]...
  • HBAN Scoops Major European Business Angel Network Award HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment, and a joint initiative of Enterprise Ireland and InterTradeIreland, was crowned Globally Networked Organisation 2018 at the recent EBAN (European Business Angel Network) Awards Ceremony held in Sofia, Bulgaria. HBAN was awarded the prominent European accolade in recognition of the significant [...]...

Diaceutics Raises €4.3 Million to Support Global Expansion

Diaceutics Raises €4.3 Million to Support Global Expansion
April 09
11:53 2018

Irish company, Diaceutics, the diagnostic commercialisation company that improves patient outcomes via better diagnostic testing, has raised €4.3 million in new mezzanine financing from two partners, WhiteRock Capital Partners and Silicon Valley Bank. The money will be used to support the organisation’s continued global expansion.

Specifically, Diaceutics will use the funding to invest in the data analytics services that it provides to pharmaceutical clients and continue to expand its global laboratory network. The company will also look to grow the internal team of experts to deliver data-driven insights designed to improve diagnostic testing that benefits patients.

A recent analysis of Diaceutics testing data revealed that, globally, over 150,000 cancer patients are missing out on potentially life-saving therapies due to substandard diagnostic testing. By investing in expanding their data sources, and continuing to build expertise in oncology and general medicine disease areas, Diaceutics will further enable pharmaceutical clients to more effectively commercialise targeted medications. The results will deliver enhanced diagnostics and more effective treatment for patients.

Over the last three years, the company has experienced revenue growth of 60% year-on-year. In 2017, it achieved revenue of $10 million and aims to reach $40 million revenue by the end of 2020. Moreover, the organisation currently works with 31 out of the world’s top 35 pharmaceutical companies. It recently, announced a partnership with Intel and Lenovo to leverage artificial intelligence in a machine learning environment to further improve the diagnosis and treatment of patients.

By working with WhiteRock Capital Partners, which works with businesses with export potential, and Silicon Valley Bank, which enables companies across the areas of technology, healthcare and data to access emerging markets across the globe, Diaceutics will continue its accelerated growth path and increase its international reach.

Speaking about the new partnerships, Peter Keeling, CEO, Diaceutics, said: “Our focus has always been, and will continue to be, helping patients benefit from better testing. Silicon Valley Bank and WhiteRock Capital Partners have been hugely supportive of this vision and we are delighted to have them as partners at the table.

“We need to continually broaden our global data capabilities and insights; this mezzanine financing allows us to keep pace with our data collection and protection infrastructure while expanding globally. Furthermore, we are eager to continue diversifying beyond our expertise in oncology into general medicine areas, and provide our pharmaceutical clients with invaluable insights that help them ensure patients who can benefit from these precision drugs are indeed receiving them.”

Andrew Gowdy, Senior Portfolio Manager, WhiteRock Capital Partners, commented: “Diaceutics is paving the way when it comes to precision medicine, transforming how patients are diagnosed and treated. Partnering with a company that is revolutionising healthcare and expanding at an incredible rate is very exciting.”

These sentiments were echoed by Clive Lennox, Director of Irish Business Development, Silicon Valley Bank, who said: “Our aim is to work with innovators who are solving real world problems and Diaceutics certainly delivers those solutions. We’re committed to supporting the burgeoning Irish technology market and we are thrilled to be involved with such a dynamic organisation, as it takes the next step in its journey and expands out into a wider range of markets.”

CAPTION:

Pictured at the announcement are (L-R): Andrew Gowdy, Senior Portfolio Manager, WhiteRock Capital Partners; Peter Keeling, CEO, Diaceutics; and Clive Lennox, Director of Irish Business Development, Silicon Valley Bank. Mandatory Credit ©Press Eye/Darren Kidd

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4